Skip to product information

Cardio Hereditary Genetic Test

Cardio Hereditary Genetic Test

Regular price $8,600.00
Regular price Sale price $8,600.00
Save Sold out
10 People are looking at this
View full details
Selected Variant Image
Cardio Hereditary Genetic Test
Regular price $8,600.00
Regular price Sale price $8,600.00
Selected Variant Image
Cardio Hereditary Genetic Test
Regular price $8,600.00
Regular price Sale price $8,600.00
  • Description

  • Why Us?

Hereditary Heart Health - 14 Conditions will be analyzed by a U.S. based lab and the lab has been accredited by the College of American Pathologists (CAP-accredited) and has Clinical Laboratory Improvement Amendments (CLIA) Certification. They will utilize next-generation sequencing to analyze all samples.

Test covers:
- Hypertrophic cardiomyopathy
- Dilated cardiomyopathy
- Left-ventricular non-compaction cardiomyopathy
- Restrictive cardiomyopathy
- Arrhythmogenic-right-ventricular cardiomyopathy
- Long QT syndrome
- Short QT syndrome
- Brugada syndrome
- Catecholaminergic-polymorphic-ventricular tachycardia
- Ehlers-Danlos syndrome (vascular)
- Familial-thoracic-aortic-aneurysms and dissections
- Loeys-Dietz syndrome
- Marfan syndrome
- Familial hypercholesterolemia

The test showed >99% accuracy in multiple validation studies.

English clinical reports will be issued by U.S. board-certified medical geneticists

A Chinese version report and a genetics counselling are also included if necessary.

Purchase Remarks: Doctors to conduct health consultation, physical examination and result report interpretation.

Clearbridge Health Limited is an integrated healthcare group with a focus on the delivery of precision medicine with businesses comprising of laboratory testing services, medical centres/clinics and strategic equity participation in complementary precision medical technology companies. We are present in more than 10 countries around the world and have plans to further expand our presence in Pan Asia. Working closely with healthcare professionals and globally-accredited laboratories, Clearbridge Health offers patient care through precision diagnostics, empowers clinicians and healthcare professionals to make reliable and accurate diagnoses, providing fresh insights into disease management, customising prevention and treatment programmes that are personalised and timely. Listed on the Catalist Board of the SGX-ST, Clearbridge Health Limited Group of Companies continues to provide effective ways to detect cancer, critical illness, and other lifestyle diseases in the world today.

VISION
Redefining healthcare in Asia with precision.
Empowering patient care with clarity.

MISSION
Setting a new standard for personalized care through the integration of healthcare services, medical technology and data science.

CORE VALUES
Kindness You always come first
Confidence We believe that better outcomes start with precise insights
Dependability Our people – they are our edge
Respect Professionalism in every circumstance
Trust Delivering healthcare services with utmost integrity